MedTrace Logo

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol

NCT03693534 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-10-08

No results posted yet for this study

Summary

A prospective study of the evaluation of the clinical IVF (in vitro fertilization) results after following Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus following Long Agonist protocol

Conditions

  • Pregnancy, Ovarian

Interventions

DIAGNOSTIC_TEST

Clinical Pregnancy Rate

The Clinical Pregnancy, Live Birth Rate and Blastulation Rate according to the protocol of COS

Sponsors & Collaborators

  • Assisting Nature

    lead OTHER

Principal Investigators

  • Evaggelos Papanikolaou, MD, PhD · Assisting Nature

  • Robert Najdecki, MD, PhD · Assisting Nature

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03693534 on ClinicalTrials.gov